Latest Technology News

Sunrise Energy Metals has attracted a significant financing interest from the U.S. Export-Import Bank, potentially securing half the capital needed for its Syerston Scandium Project amid shifting global supply dynamics.

Victory Metals Limited has reported exceptional heavy rare earth element assay results from its North Stanmore Project, revealing some of the highest Dysprosium and Terbium grades ever recorded in clay-hosted deposits globally.

Metallium Limited and Ucore Rare Metals have entered a binding 12-month collaboration to integrate their cutting-edge technologies, aiming to establish the first fully U.S.-based rare earth element refining pathway and reduce reliance on Chinese supply chains.

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

Pantera Lithium has won strong shareholder approval for its sale of Daytona Lithium to EnergyX, with due diligence complete and closing expected soon. Meanwhile, Pantera is broadening its US critical minerals portfolio beyond lithium.

First Graphene’s UK partner Vector Group has filed patents for novel fire-resistant materials enhanced with PureGRAPH graphene, showing 100% self-extinguishing performance and improved safety for construction.

Oceania Healthcare has unveiled a comprehensive strategy focused on sales performance, operational excellence, and capital management to strengthen its aged care and retirement living portfolio. The company aims to reduce debt, enhance resident choice, and expand services while maintaining strong occupancy and shareholder returns.

Jatcorp has officially appointed Dr Xinpeng (Sean) Li as its CEO, locking in a three-year contract that underscores a strategic focus on sustainable growth and innovation.

Thrive Tribe Technologies has raised approximately $500,000 through a discounted share placement, aiming to bolster its working capital. The move follows shareholder approval and involves a significant issuance of new shares.

Alterity Therapeutics has unveiled encouraging Phase 2 trial results for ATH434, demonstrating its potential to slow disease progression in Multiple System Atrophy while maintaining a strong safety profile.

Spacetalk Ltd has raised $4.05 million through a combination of a conditional placement and convertible notes to accelerate its geographic expansion and app development, alongside appointing a seasoned director to its board.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.